Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05499520
Other study ID # 11022
Secondary ID R01CA237670
Status Completed
Phase N/A
First received
Last updated
Start date September 21, 2022
Est. completion date August 15, 2023

Study information

Verified date November 2023
Source Abramson Cancer Center at Penn Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.


Description:

This study will recruit 3000 young adult sexual minority women (SMW), ages 18-30 years, current smokers (n = 1500) and not current smokers (n = 1500). The study will determine the effects of varying the dose (single vs. multiple), and latency (immediate vs. delayed) of showing participants inoculation anti-smoking messages on smoking and quitting intentions. The study team hypothesize that the multiple exposures (vs. single), and delayed exposure (vs. immediate) will be associated with increased resistance to marketing, reduced smoking intention, and increased quitting intention. The study team will further explore the mechanisms of inoculation effects through emotions, beliefs, and attitudes towards tobacco companies. Participants will be asked to complete a baseline survey and then will receive an anti-smoking message in varying dosages based on the condition they are assigned with a control group receiving no message. Participants will then see a pro-smoking or threat message immediately, one week, or one month late, depending on the condition they were assigned.


Recruitment information / eligibility

Status Completed
Enrollment 2591
Est. completion date August 15, 2023
Est. primary completion date July 5, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Ages 18-30 - Woman - Identifies as a sexual minority (any sexual orientation other than heterosexual) - Lives in the United States - Able to take surveys in English Exclusion Criteria: - Under 18 or older than 30 - Men - Heterosexual - Lives outside the United States - Unable to take the survey in English

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Culturally Tailored Anti-Smoking Messages
Anti-smoking messages will be administered online via a Qualtrics survey.

Locations

Country Name City State
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (6)

Lead Sponsor Collaborator
Abramson Cancer Center at Penn Medicine Dana-Farber Cancer Institute, Fenway Community Health, Harvard School of Public Health (HSPH), National Cancer Institute (NCI), Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in intention to quit smoking Change in intention to quit smoking will be measured using the Burkhalter intention to quit smoking scale. This is a four item scale that measures readiness to cut down or quit smoking in the next 30 days. This will only be measured among current smokers. Lowest mean score is 1 and highest mean score is 7. Higher scores indicate increased intention to quit smoking. Days 0, 30
Primary Change in intention to purchase cigarettes Change in intention to purchase cigarettes will be measured using the Juster single item consumer buying intention scale to measure how likely participants who are not current smokers are to purchase cigarettes. Response options range from 0 to 10 with 10 indicating a higher likelihood of purchasing cigarettes. Days 0, 30
See also
  Status Clinical Trial Phase
Completed NCT04812795 - Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches N/A
Completed NCT02785484 - Impact of Cigarette Pack Constituent Disclosures N/A
Recruiting NCT06072547 - Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART N/A
Completed NCT02301351 - Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors N/A
Completed NCT03339206 - Enhancing Source Credibility in Tobacco Regulatory Communications N/A
Recruiting NCT03568799 - 4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules N/A
Completed NCT01359709 - Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking Phase 1
Completed NCT02448225 - 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Phase 2
Completed NCT01921439 - OCAST Cessation Study N/A
Completed NCT02921282 - Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms